한글목차

올리고뉴클레오티드 합성 시장(2025-2029년)

올리고뉴클레오티드 합성 시장은 2024-2029년 47억 4,630만 달러로 예측 기간 동안 17.4%의 CAGR로 성장할 것으로 예상됩니다. 세계의 올리고뉴클레오티드 합성 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 정리하여 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 RNA 기반 치료제로의 전환 증가, 치료 및 진단 도구로서 올리고뉴클레오티드의 사용 증가, 올리고뉴클레오티드 합성의 기술 혁신에 의해 주도되고 있습니다.

이 보고서는 올리고뉴클레오티드 합성에 AI와 자동화의 통합이 향후 몇 년 동안 올리고뉴클레오티드 합성 시장 성장을 촉진하는 주요 이유 중 하나라고 지적합니다. 또한, 올리고뉴클레오티드 합성에 대한 연구 및 자금 조달의 증가, 저비용 및 고처리량 올리고뉴클레오티드 합성에 대한 수요 증가는 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio에 의한 분석

• 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망(2024-2029년)

제5장 시장 규모 실적

• 올리고뉴클레오티드 합성 세계 시장(2019-2023년)
• 용도별 부문 분석(2019-2023년)
• 최종사용자별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 올리고뉴클레오티드 합성 세계 시장

제7장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제8장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• PCR 프라이머 : 시장 규모와 예측(2024-2029년)
• PCR 어세이와 패널 : 시장 규모와 예측(2024-2029년)
• DNA 마이크로어레이 : 시장 규모와 예측(2024-2029년)
• FISH(Fluorescence in situ hybridization) : 시장 규모와 예측(2024-2029년)
• 기타 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 용도별

제9장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 제약·바이오테크놀러지 기업 : 시장 규모와 예측(2024-2029년)
• 학술연구기관 : 시장 규모와 예측(2024-2029년)
• 진단 검사실 : 시장 규모와 예측(2024-2029년)
• 병원 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 최종사용자별

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 한국 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제12장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Agilent Technologies Inc.
• Ansa Biotechnologies
• Biogen Inc.
• Biotage AB
• Danaher Corp.
• General Electric Co.
• Kaneka Corp.
• LGC Science Group Holdings Ltd.
• Merck KGaA
• Mettler Toledo International Inc.
• QIAGEN N.V.
• Sarepta Therapeutics Inc.
• Synbio Technologies LLC
• Syngene International Ltd.
• Thermo Fisher Scientific Inc.

제15장 부록

영문목차

Oligonucleotide Synthesis Market 2025-2029

The oligonucleotide synthesis market is forecasted to grow by USD 4746.3 mn during 2024-2029, accelerating at a CAGR of 17.4% during the forecast period. The report on the oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing shift toward rna-based therapeutics, increasing use of oligonucleotides as therapeutic and diagnostic tools, and technological innovations in oligonucleotide synthesis.

Technavio's oligonucleotide synthesis market is segmented as below:

By Application

• PCR primers
• PCR assays and panels
• DNA microarrays
• Fluorescence in situ hybridization
• Others

By End-user

• Pharmaceutical and biotechnology companies
• Research and academic institutes
• Diagnostic laboratories
• Hospitals

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the integration of ai and automation in oligonucleotide synthesis as one of the prime reasons driving the oligonucleotide synthesis market growth during the next few years. Also, increasing research and funding for oligonucleotide synthesis and rise in demand for low-cost and high-throughput oligonucleotide synthesis will lead to sizable demand in the market.

The report on the oligonucleotide synthesis market covers the following areas:

• Oligonucleotide Synthesis Market sizing
• Oligonucleotide Synthesis Market forecast
• Oligonucleotide Synthesis Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Bio Pharma Services, Alnylam Pharmaceuticals Inc., Amgen Inc., Ansa Biotechnologies, Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Merck KGaA, Mettler Toledo International Inc., QIAGEN N.V., Sarepta Therapeutics Inc., Synbio Technologies LLC, Syngene International Ltd., and Thermo Fisher Scientific Inc.. Also, the oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Oligonucleotide Synthesis Market 2019 - 2023
  • Historic Market Size - Data Table on Global Oligonucleotide Synthesis Market 2019 - 2023 ($ million)
• 5.2 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.5 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on global oligonucleotide synthesis market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

• 8.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 8.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 8.3 PCR primers - Market size and forecast 2024-2029
  • Chart on PCR primers - Market size and forecast 2024-2029 ($ million)
  • Data Table on PCR primers - Market size and forecast 2024-2029 ($ million)
  • Chart on PCR primers - Year-over-year growth 2024-2029 (%)
  • Data Table on PCR primers - Year-over-year growth 2024-2029 (%)
• 8.4 PCR assays and panels - Market size and forecast 2024-2029
  • Chart on PCR assays and panels - Market size and forecast 2024-2029 ($ million)
  • Data Table on PCR assays and panels - Market size and forecast 2024-2029 ($ million)
  • Chart on PCR assays and panels - Year-over-year growth 2024-2029 (%)
  • Data Table on PCR assays and panels - Year-over-year growth 2024-2029 (%)
• 8.5 DNA microarrays - Market size and forecast 2024-2029
  • Chart on DNA microarrays - Market size and forecast 2024-2029 ($ million)
  • Data Table on DNA microarrays - Market size and forecast 2024-2029 ($ million)
  • Chart on DNA microarrays - Year-over-year growth 2024-2029 (%)
  • Data Table on DNA microarrays - Year-over-year growth 2024-2029 (%)
• 8.6 Fluorescence in situ hybridization - Market size and forecast 2024-2029
  • Chart on Fluorescence in situ hybridization - Market size and forecast 2024-2029 ($ million)
  • Data Table on Fluorescence in situ hybridization - Market size and forecast 2024-2029 ($ million)
  • Chart on Fluorescence in situ hybridization - Year-over-year growth 2024-2029 (%)
  • Data Table on Fluorescence in situ hybridization - Year-over-year growth 2024-2029 (%)
• 8.7 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.8 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
  • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
  • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
  • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
• 9.4 Research and academic institutes - Market size and forecast 2024-2029
  • Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
  • Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
  • Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
  • Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
• 9.5 Diagnostic laboratories - Market size and forecast 2024-2029
  • Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
  • Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
  • Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
  • Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
• 9.6 Hospitals - Market size and forecast 2024-2029
  • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 11.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 11.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 11.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 11.8 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 11.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 11.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 11.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 11.12 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 11.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 11.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 11.15 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 11.16 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 14.5 Ansa Biotechnologies
  • Ansa Biotechnologies - Overview
  • Ansa Biotechnologies - Product / Service
  • Ansa Biotechnologies - Key offerings
  • SWOT
• 14.6 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key news
  • Biogen Inc. - Key offerings
  • SWOT
• 14.7 Biotage AB
  • Biotage AB - Overview
  • Biotage AB - Product / Service
  • Biotage AB - Key offerings
  • SWOT
• 14.8 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 14.9 General Electric Co.
  • General Electric Co. - Overview
  • General Electric Co. - Business segments
  • General Electric Co. - Key news
  • General Electric Co. - Key offerings
  • General Electric Co. - Segment focus
  • SWOT
• 14.10 Kaneka Corp.
  • Kaneka Corp. - Overview
  • Kaneka Corp. - Business segments
  • Kaneka Corp. - Key news
  • Kaneka Corp. - Key offerings
  • Kaneka Corp. - Segment focus
  • SWOT
• 14.11 LGC Science Group Holdings Ltd.
  • LGC Science Group Holdings Ltd. - Overview
  • LGC Science Group Holdings Ltd. - Product / Service
  • LGC Science Group Holdings Ltd. - Key offerings
  • SWOT
• 14.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 14.13 Mettler Toledo International Inc.
  • Mettler Toledo International Inc. - Overview
  • Mettler Toledo International Inc. - Business segments
  • Mettler Toledo International Inc. - Key news
  • Mettler Toledo International Inc. - Key offerings
  • Mettler Toledo International Inc. - Segment focus
  • SWOT
• 14.14 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key news
  • QIAGEN N.V. - Key offerings
  • SWOT
• 14.15 Sarepta Therapeutics Inc.
  • Sarepta Therapeutics Inc. - Overview
  • Sarepta Therapeutics Inc. - Product / Service
  • Sarepta Therapeutics Inc. - Key offerings
  • SWOT
• 14.16 Synbio Technologies LLC
  • Synbio Technologies LLC - Overview
  • Synbio Technologies LLC - Product / Service
  • Synbio Technologies LLC - Key offerings
  • SWOT
• 14.17 Syngene International Ltd.
  • Syngene International Ltd. - Overview
  • Syngene International Ltd. - Product / Service
  • Syngene International Ltd. - Key offerings
  • SWOT
• 14.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations